Fang HW#, Tseng PL#(co-first), Hu TH, Wang JH, Hung CH, Lu SN, Chen CH*. Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy. Virol J. 2024 Apr 3;21(1):79. (SCI) B型肝炎癌症病人接受貝樂克或韋立得預防性用藥停藥後B型肝炎復發的比較 doi: 10.1186/s12985-024-02338-6.
Fang HW, Hu TH, Wang JH, Hung CH, Lu SN, Chen CH*. Post-treatment HBsAg decline predicts high rate of HBsAg loss after stopping entecavir or tenofovir in HBeAg-negative patients without retreatment. Dig Liver Dis. 2023 Sep;55(9):1223-1229. (SCI) 停藥後B型肝炎表面抗原的下降可以預測e抗原陰性停貝樂克或惠立妥治療後沒有再治療病人高表面抗原消失的比率 j.dld.2023.02.006_
Fang HW, Yen YH, Hung CH, Wang JH, Hu TH, Lu SN, Chen CH*. Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir orTenofovir. Dig Dis Sci. 2022 Jul;67(7):3402-3411. (SCI) 病人停藥貝樂克或惠立妥發生臨床復發後病毒抑制的預測因子
Fang HW, Chiang PH, Huang YC*. Livestock-associated methicillin-resistant Staphylococcus aureus ST9 in pigs and related personnel in Taiwan. PLoS One. 2014 Feb 13;9(2):e88826. (SCI) 家畜相關Methicillin抗藥性金黃色葡萄球菌ST9菌株在台灣豬隻、飼主及屠宰廠業者的帶菌情形
